Gossamer Bio (GOSS) EBITDA Margin (QoQ) (2024 - 2026)
Gossamer Bio (GOSS) EBITDA Margin (QoQ) (2024 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.00 Bn | 132.14 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.31 Bn | 78.32 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.24 Bn | 60.06 Bn | 1.37 Bn |
| 4 | Moderna | 62.41 Bn | 57.27 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.25 Bn | 37.15 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.18 Bn | 27.88 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.93 Bn | 10.54 Bn | 668.28 Mn |
| 8 | Insmed | 27.55 Bn | 26.39 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.28 Bn | 26.44 Bn | - |
| 10 | Gossamer Bio | 47.78 Mn | -9.25 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1,763.00 |
| Mar 31, 2026 | 6,902.00 |
| Dec 31, 2025 | 3,580.00 |
| Sep 30, 2025 | -3,204.00 |
| Jun 30, 2025 | 3,482.00 |
| Mar 31, 2025 | -61,931.00 |
| Dec 31, 2024 | 60,488.00 |
| Sep 30, 2024 | -41,214.00 |